SCHEMBL742011

SCHEMBL742011

C=C(C#N)S(=O)(=O)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 3/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
HPGD P15428 4/20 0.45
ALDH1A1 P00352 6/20 0.44
KMT2A Q03164 4/20 0.44
HSD17B10 Q99714 4/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
MEN1 O00255 3/20 0.44
KDM4E B2RXH2 3/20 0.44
TDP1 Q9NUW8 2/20 0.44
POLB P06746 1/20 0.44
GAA P10253 1/20 0.44
ALPG P10696 1/20 0.44
ALOX15 P16050 1/20 0.44
ALOX12 P18054 1/20 0.44
TSHR P16473 1/20 0.43
MAPT P10636 3/20 0.41
HTR6 P50406 1/20 0.41
CA1 P00915 2/20 0.39
CA2 P00918 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28764074 0.89 HPGD (0.41) PKML3MBTL1HPGDALDH1A1KMT2A
SCHEMBL11879645 0.80 TSHR (0.47) PKMALDH1A1KMT2ASMN1; SMN2MEN1
SCHEMBL11152641 0.80 HPGD (0.47) PKMHPGDALDH1A1KMT2AHSD17B10
SCHEMBL28938490 0.78 KMT2A (0.44) L3MBTL1HPGDALDH1A1KMT2AHSD17B10
SCHEMBL12220338 0.77 TDP1 (0.53) PKML3MBTL1HPGDALDH1A1KMT2A
SCHEMBL10599045 0.77 SMN1; SMN2 (0.55) L3MBTL1ALDH1A1KMT2AHSD17B10SMN1; SMN2
SCHEMBL27640914 0.77 PKM (0.47) PKML3MBTL1HPGDALDH1A1KMT2A
SCHEMBL9276097 0.76 KIF11 (0.43) KMT2AMEN1MAPTCA1CA2
SCHEMBL29432580 0.76 ALDH1A1 (0.49) HPGDALDH1A1KMT2AHSD17B10SMN1; SMN2
SCHEMBL18181485 0.75 PKM (0.46) PKML3MBTL1HPGDALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138356-B2 Chemical inhibitors of inhibitors of differentiation Angiogeney, Inc. (US) 2012-03-20 US disclosed
US-8039532-B2 Heterocyclic compound, ultraviolet absorbent and composition containing the same FUJIFILM CORPORATION (JP) 2011-10-18 US disclosed
US-20100210762-A1 HETEROCYCLIC COMPOUND, ULTRAVIOLET ABSORBENT AND COMPOSITION CONTAINING THE SAME FUJIFILM CORPORATION (JP) 2010-08-19 US disclosed
US-20100130638-A1 ULTRAVIOLET ABSORBENT COMPOSITION FUJIFILM CORPORATION (JP) 2010-05-27 US disclosed
US-20100025642-A1 ULTRAVIOLET ABSORBENT COMPOSITION FUJIFILM CORPORATION (JP) 2010-02-04 US disclosed
US-20090240067-A1 METHOD OF PRODUCING A BISBENZODITHIOL COMPOUND FUJIFILM CORPORATION (JP) 2009-09-24 US disclosed
US-20090226422-A1 Chemical Inhibitors of Inhibitors of Differentiation ANGIOGENEX 2009-09-10 US disclosed
US-20090181948-A1 DIAMINE DERIVATIVE KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-07-16 US disclosed
EP-1847530-A1 DIAMINE DERIVATIVE KYOWA HAKKO KOGYO CO., LTD. (JP) 2007-10-24 EP disclosed
US-7138108-B2 Photoprotective UV-screening compositions comprising (phenylsulfonyl) acrylonitrile-substituted silanes/siloxanes L'OREAL (FR) 2006-11-21 US disclosed
WO-1995024190-A2 RECEPTOR TYROSINE KINASE INHIBITORS FOR INHIBITING CELL PROLIFERATIVE DISORDERS AND COMPOSITIONS THEREOF SUGEN, INC. (US) 1995-09-14 WO disclosed
US-5308608-A Compounds for destroying viruses, cells and tissues UNIVERSITY OF BRITISH COLUMBIA (CA) 1994-05-03 US disclosed
US-5149708-A Useful for detection and treatment of malignant cells, combined with irradiation UNIVERSITY OF BRITISH COLUMBIA (CA) 1992-09-22 US disclosed
EP-0476011-A1 PHOTOSENSITIZING DIELS-ALDER PORPHYRIN DERIVATIVES THE UNIVERSITY OF BRITISH COLUMBIA (CA) 1992-03-25 EP disclosed
WO-1990015059-A1 PHOTOSENSITIZING DIELS-ALDER PORPHYRIN DERIVATIVES THE UNIVERSITY OF BRITISH COLUMBIA (CA) 1990-12-13 WO disclosed
US-4093644-A MICROBIOCIDES THE DOW CHEMICAL COMPANY (US) 1978-06-06 US disclosed
US-4049694-A BACTERICIDE, FUNGICIDE THE DOW CHEMICAL COMPANY (US) 1977-09-20 US disclosed
US-4049696-A BACTERICIDE, FUNGICIDE THE DOW CHEMICAL COMPANY (US) 1977-09-20 US disclosed
US-4049695-A BACTERICIDE, FUNGICIDE THE DOW CHEMICAL COMPANY (US) 1977-09-20 US disclosed
US-3976668-A MICROBIOCIDE SANITIZED, INC. (US) 1976-08-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100210762-A1 HETEROCYCLIC COMPOUND, ULTRAVIOLET ABSORBENT AND COMPOSITION CONTAINING THE SAME F12, F2, CYP24A1 PKM 4094/4885L3MBTL1 3500/4885HPGD 547/4885
US-20090181948-A1 DIAMINE DERIVATIVE ARG1, PRMT5, PRMT1 PKM 3834/4885L3MBTL1 2665/4885HPGD 349/4885
US-20090240067-A1 METHOD OF PRODUCING A BISBENZODITHIOL COMPOUND SQOR, NQO1, PBRM1 PKM 1051/4885L3MBTL1 2663/4885HPGD 785/4885
US-20090226422-A1 Chemical Inhibitors of Inhibitors of Differentiation BRAF, MAPK1, RAF1 PKM 2593/4885L3MBTL1 2309/4885HPGD 3243/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.